APRO Korea is a leading medical device manufacturer specializing in advanced electrosurgical units (SENCE) and radiofrequency thermal lesion generators (Coatherm) that integrate precise power control with innovative pulse-based energy delivery.

In the current global market, major products such as Medtronic’s NT2000 (U.S.), Boston Scientific’s G4 (U.S.), Baylis by Kimberly-Clark (Canada), and Coatherm by APRO Korea (Korea) dominate the radiofrequency thermal generator segment.
However, these systems are positioned at a significantly higher price level compared to general electrosurgical units, creating a need for a more accessible and efficient alternative.

Through the development of pulse-controlled energy modulation, APRO Korea aims to lead the transformation of the electrosurgical market.
Building upon our existing core technologies, we have enhanced stability, usability, and treatment precision — enabling micro-level voltage, current, and pulse control. These innovations have positioned us as a global leader in next-generation surgical energy systems.

While current radiofrequency thermal generators deliver excellent therapeutic outcomes, their high cost has limited adoption in clinical settings.
APRO Korea’s engineering advancements significantly reduce production costs while maintaining premium performance, thus expanding treatment accessibility across broader medical environments.

The development of such innovative systems not only drives market expansion through globally competitive products but also strengthens the global competitiveness of the Korean medical device industry.
Our Coatherm system was selected as a World-Class Product of Korea (Ministry of Trade, Industry and Energy, 2022), a recognition of our technological excellence and contribution to medical innovation worldwide.